(HealthDay)—A COVID-19 vaccine still awaiting U.S. Food and Drug Administration approval may prove to be a powerful weapon in fighting the pandemic, according to its developers.
(HealthDay)—Provider teams outperform solo providers for management of three new-onset chronic diseases, while among solo providers, care management and outcome differ little between physicians and nonphysicians, […]
Darzi and colleagues are right to highlight research recruitment, because, before the pandemic, research activity had fallen in almost all specialties in England.1 The Principle study, […]